[RF9, a powerful and selective antagonist of the neuropeptide FF receptors, prevents the development of the tolerance to opioids].
Bourguignon
Jean-Jacques
JJ
Simonnet
Guy
G
Simonin
Frédéric
F
D000218:Adamantane / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004151:Dipeptides / Q000627:therapeutic use*; D004361:Drug Tolerance / Q000502:physiology*; D006801:Humans; D006930:Hyperalgesia / Q000517:prevention & control*; D009293:Opioid-Related Disorders / Q000503:physiopathology*; D018013:Receptors, Neuropeptide / Q000037:antagonists & inhibitors* / Q000502:physiology*
D004151:Dipeptides; D018013:Receptors, Neuropeptide; C508361:adamantylcarbonyl-arginyl-phenylalaninamide; C083929:neuropeptide FF receptor; D000218:Adamantane